Table 1.
The demographic and clinical variables of the six patients
| No. | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Gender | Female | Male | Female | Female | Female | Male |
| Age | 69 | 72 | 73 | 79 | 71 | 52 |
| Site of primary tumor | RCC (lt.) | RCC (rt.) | RCC (lt.) | RCC (lt.) | RCC (lt.) | Rectal cancer |
| Pathological diagnosis of primary tumor | N/A | Clear cell carcinoma | Clear cell carcinoma | Clear cell carcinoma | N/A | Well-differentiated adenocarcinoma |
| Pathological stage of primary tumor | N/A | T1bN0M0 | T1bN0M0 | T2 | N/A | T3N2aM0 |
| Interval from primary site resection | 12 y | 1 y and 4 m | 14 y and 2 m | 6 y and 3 m | 15 y | 6 y and 4 m |
| Location of pancreatic tumor | Tail | Tail | Head/body/tail | Head | Tail | Head |
| Tumor size | 35 mm | 26 mm | 22/34/11 mm | 31 mm | 16 mm | 33 mm |
| Vascularity | Hyper | Hyper | N/A | Hyper | Hyper | Ring-enhanced |
| Surgical procedure | DP | DP | TP | PD | DP | PD |
| Lymph node metastasis | Negative | Negative | Negative | Negative | Negative | Negative |
| Morbidity | Peptic ulcer | – | – | – | – | Intra-abdominal abscess |
| Prognosis | Alive | Alive | Alive | Alive | Alive | Dead |
| Survival time after pancreatectomy | 9 y and 5 m | 1 y and 6 m | 1 y and 6 m | 1 y and 1 m | 3 m | 2 y and 5 m |
RCC renal cell carcinoma, lt left side, rt. right side, N/A not available, y year(s), m month(s), DP distal pancreatectomy, TP total pancreatectomy, PD pancreatoduodenectomy